Table 2.
Clinical, psychological, social and self-management assessments of PWE
| Scale | Result |
|---|---|
| Years since epilepsy diagnosis, mean (SD); median,[range] (n = 403) | 21.2 (15.5); 18 [1, 66] |
| Seizure frequency n (%), (n = 404) | |
| 1–3 | 49 (12.1) |
| 4–5 | 51 (12.6) |
| 7–9 | 24 (5.9) |
| 10+ | 280 (69.3) |
| Days since last seizure (n = 383), median (IQR) [range] | 34 (18, 63) [1, 351] |
| Co-morbidities n (%) | |
| No | 219 (54.2) |
| Yes, another medical condition | 132 (32.7) |
| Yes, psychiatric condition | 20 (5.0) |
| Yes, both medical and psychiatric conditions | 33 (8.2) |
| HADS anxiety n (%), (n = 403) | |
| Normal (0–7) | 187 (46.4) |
| Borderline (8–10) | 79 (19.6) |
| Case (≥11) | 137 (34.0) |
| HADS depression n (%), (n = 403) | |
| Normal (0–7) | 290 (72.0) |
| Borderline (8–10) | 71 (17.6) |
| Case (≥11) | 42 (10.4) |
| Stigma of epilepsy n (%), (n = 401) | |
| Not stigmatized (0) | 148 (36.9) |
| Mild-moderate (1–6) | 203 (50.6) |
| Highly stigmatized (7–9) | 50 (12.5) |
| Self-Mastery of Epilepsy Scale, mean (SD) [range], (n = 399) | 14.1 (3.3) [6, 24] |
| Medication Adherence Scale, mean (SD) [range], (n = 399) | 45.4 (4.8) [16.7, 50] |